Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 6, 2015, Pages 639-646

  Tsai, Hsing Chen ^a,b   Huang, Li Min ^a   Chang, Luan Yin ^a   Lee, Ping Ing ^a   Chen, Jong Ming ^a   Shao, Pei Lan ^a   Hsueh, Po Ren ^a   Sheng, Wang Huei ^a   Chang, Yu Ching ^a   Lu, Chun Yi ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Antimicrobial lock therapy; Bloodstream infection; Central catheter; Hematology oncology; Pediatric

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFAZOLIN; CEFTAZIDIME; CHLORHEXIDINE; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; MINOCYCLINE; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT; DISINFECTANT AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ANTIMICROBIAL LOCK THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; CANDIDEMIA; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISINFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; FEMALE; FOLLOW UP; GAUZE DRESSING; HUMAN; INFANT; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PREVALENCE; SEX DIFFERENCE; TAIWAN; ADVERSE EFFECTS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; ENTEROBACTERIACEAE INFECTIONS; INFECTION CONTROL; ISOLATION AND PURIFICATION; LEUKEMIA, MYELOID, ACUTE; METABOLISM; MICROBIOLOGY; PRESCHOOL CHILD; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

ADOLESCENT; ANTI-INFECTIVE AGENTS; BACTEREMIA; C-REACTIVE PROTEIN; CANDIDEMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CENTRAL VENOUS CATHETERS; CHILD; CHILD, PRESCHOOL; CHLORHEXIDINE; DISINFECTANTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INFECTION CONTROL; LEUKEMIA, MYELOID, ACUTE; MALE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 84951280770     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.07.008     Document Type: Article

References (31)

1. Wolf J., Curtis N., Worth L.J., Flynn P.M. Central line-associated bloodstream infection in children: an update on treatment. Pediatr Infect Dis J 2013, 32:905-910.
2. Groeger J.S., Lucas A.B., Thaler H.T., Friedlander-Klar H., Brown A.E., Kiehn T.E., et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993, 119:1168-1174.
3. Astagneau P., Maugat S., Tran-Minh T., Douard M.C., Longuet P., Maslo C., et al. Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study. Infect Control Hosp Epidemiol 1999, 20:494-498.
4. Lebeaux D., Larroque B., Gellen-Dautremer J., Leflon-Guibout V., Dreyer C., Bialek S., et al. Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature. Medicine (Baltimore) 2012, 91:309-318.
5. Bartram J.L., O'Driscoll S., Kulasekararaj A.G., Height S.E., Dick M., Patel S., et al. Portacaths are safe for long-term regular blood transfusion in children with sickle cell anaemia. Arch Dis Child 2011, 96:1082-1084.
6. Mouw E., Chessman K., Lesher A., Tagge E. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. J Pediatr Surg 2008, 43:1025-1029.
7. O'Horo J.C., Silva G.L., Safdar N. Anti-infective locks for treatment of central line-associated bloodstream infection: a systematic review and meta-analysis. Am J Nephrol 2011, 34:415-422.
8. Mermel L.A., Allon M., Bouza E., Craven D.E., Flynn P., O'Grady N.P., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49:1-45.
9. O'Grady N.P., Alexander M., Burns L.A., Dellinger E.P., Garland J., Heard S.O., et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011, 52:162-193.
10. Johnson D.C., Johnson F.L., Goldman S. Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr Infect Dis J 1994, 13:930-931.
11. Bailey E., Berry N., Cheesbrough J.S. Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis. J Antimicrob Chemother 2002, 50:615-617.
12. Lee M.Y., Ko K.S., Song J.H., Peck K.R. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae. J Antimicrob Chemother 2007, 60:782-787.
13. Wolosker N., Yazbek G., Munia M.A., Zerati A.E., Langer M., Nishinari K. Totally implantable femoral vein catheters in cancer patients. Eur J Surg Oncol 2004, 30:771-775.
14. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
15. Kliegman R.M., Stanton B.F., Geme J.W., Schor N.F., Behrman R.E. Nelson textbook of pediatrics 2011, Saunders, Philadelphia, PA. 19th ed.
16. Celebi S., Sezgin M.E., Cakir D., Baytan B., Demirkaya M., Sevinir B., et al. Catheter-associated bloodstream infections in pediatric hematology-oncology patients. Pediatr Hematol Oncol 2013, 30:187-194.
17. Rinke M.L., Milstone A.M., Chen A.R., Mirski K., Bundy D.G., Colantuoni E., et al. Ambulatory pediatric oncology CLABSIs: epidemiology and risk factors. Pediatr Blood Cancer 2013, 60:1882-1889.
18. Wu P.P., Liu C.E., Chang C.Y., Huang H.C., Syu S.S., Wang C.H., et al. Decreasing catheter-related bloodstream infections in the intensive care unit: interventions in a medical center in central Taiwan. J Microbiol Immunol Infect 2012, 45:370-376.
19. Kao H.F., Chen I.C., Hsu C., Chang S.Y., Chien S.F., Chen Y.C., et al. Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers. Support Care Cancer 2014, 22:1189-1197.
20. Berrueco R., Rives S., Català A., Toll T., Gene A., Ruiz A., et al. Prospective surveillance study of blood stream infections associated with central venous access devices (port-type) in children with acute leukemia: an intervention program. J Pediatr Hematol Oncol 2013, 35:e194-e199.
21. Flynn P.M., Willis B., Gaur A.H., Shenep J.L. Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 2003, 21:3520-3525.
22. Allen R.C., Holdsworth M.T., Johnson C.A., Chavez C.M., Heideman R.L., Overturf G., et al. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 2008, 51:53-58.
23. Abbas A.A., Fryer C.J., Paltiel C., Chedid F., Felimban S.K., Yousef A.A., et al. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatr Blood Cancer 2004, 42:325-331.
24. Wurzel C.L., Halom K., Feldman J.G., Rubin L.G. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child 1988, 142:536-540.
25. Handrup M.M., Møller J.K., Frydenberg M., Schrøder H. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2010, 55:309-313.
26. Adler A., Yaniv I., Steinberg R., Solter E., Samra Z., Stein J., et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006, 62:358-365.
27. Smith T.L., Pullen G.T., Crouse V., Rosenberg J., Jarvis W.R. Bloodstream infections in pediatric oncology outpatients: a new healthcare systems challenge. Infect Control Hosp Epidemiol 2002, 23:239-243.
28. Severien C., Nelson J.D. Frequency of infections associated with implanted systems vs cuffed, tunneled Silastic venous catheters in patients with acute leukemia. Am J Dis Child 1991, 145:1433-1438.
29. De Sio L., Jenkner A., Milano G.M., Ilari I., Fidani P., Castellano A., et al. Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients. Pediatr Infect Dis J 2004, 23:963-965.
30. Chen P.Y., Chuang Y.C., Wang J.T., Sheng W.H., Yu C.J., Chu C.C., et al. Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010. J Microbiol Immunol Infect 2014, 47:95-103.
31. Ruschulte H., Franke M., Gastmeier P., Zenz S., Mahr K.H., Buchholz S., et al. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol 2009, 88:267-272.